Contact this trialFirst, we need to learn more about you.
Non-pharmacological Therapy
MagPro X100 Stimulator for Depression
Recruiting1 award5 criteria
Toronto, Ontario
This trial is testing a new, high-dose protocol for aiTBS (a type of brain stimulation therapy) in patients with unipolar depression who have responded to ECT in the past, or who urgently need treatment due to symptom severity during the COVID-19 pandemic.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.